Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NeuroOne Medical Technologies ( (NMTC) ) has provided an announcement.
On April 14, 2026, NeuroOne Medical Technologies Corporation filed an amendment to its certificate of incorporation to implement a 1-for-6 reverse stock split of its common stock, following stockholder approval and board authorization at the company’s April 3, 2026 annual meeting. The reverse split will reclassify every six existing shares into one new share, with proportional adjustments to equity incentive plans, stock options and warrants, and cash payments in lieu of fractional shares.
The reverse stock split will take effect at 5:00 p.m. Eastern Time on April 15, 2026, and NeuroOne’s shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market under the existing ticker “NMTC” on April 16, 2026, with a new CUSIP number assigned. The move leaves the number of authorized shares and par value unchanged and is expected to uniformly affect all stockholders without altering their relative ownership stakes, aside from minor differences due to the treatment of fractional shares.
The most recent analyst rating on (NMTC) stock is a Buy with a $1.50 price target. To see the full list of analyst forecasts on NeuroOne Medical Technologies stock, see the NMTC Stock Forecast page.
Spark’s Take on NMTC Stock
According to Spark, TipRanks’ AI Analyst, NMTC is a Neutral.
The score is primarily weighed down by persistent losses and significant negative free cash flow despite improved gross margins and low leverage. Technicals are mixed but trend weak given the stock is below major moving averages. Valuation support is limited due to negative earnings and no dividend. Earnings-call guidance and product/program progress provide some offset, but liquidity/runway concerns cap upside.
To see Spark’s full report on NMTC stock, click here.
More about NeuroOne Medical Technologies
NeuroOne Medical Technologies Corporation operates in the medical technology sector, focusing on advanced neurotechnology solutions designed for neurological applications. The company’s equity structure and stock market listing on the Nasdaq Capital Market are central to its access to capital and its visibility among public-market investors.
Average Trading Volume: 206,779
Technical Sentiment Signal: Strong Sell
Current Market Cap: $37.09M
Find detailed analytics on NMTC stock on TipRanks’ Stock Analysis page.